Bristol-Myers Squibb Company (BMY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | BMY | GILD | VRTX | ||
| Company | Bristol-Myers Squibb Company | Gilead Sciences Inc | Vertex Pharmaceutic | ||
| Price Information | |||||
| Exchange | NYSE | NASDAQ | NASDAQ | ||
| Open | 62.69 | 130.02 | 474.10 | ||
| High | 65.56 | 131.36 | 480.26 | ||
| Low | 62.23 | 128.28 | 470.54 | ||
| Last | 64.87 | 131.26 | 481.77 | ||
| Change | +1.77 | -1.47 | -1.56 | ||
| Percent Change | +2.81% | -1.11% | -0.32% | ||
| Volume | 14,040,323 | 4,062,843 | 671,981 | ||
| 20-Day Average Volume | 10,525,618 | 6,514,315 | 1,465,365 | ||
| Previous | 63.10 | 132.73 | 483.33 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 60.10 | 132.22 | 489.18 | ||
| 20-Day Raw Stochastic | 96.07% | 34.28% | 21.64% | ||
| 20-Day Relative Strength | 66.37 | 50.59 | 51.81 | ||
| Weighted Alpha | +48.01 | +11.97 | +9.15 | ||
| Today's Opinion | 72% Buy | 24% Sell | 88% Buy | ||
| Yesterday's Opinion | 72% Buy | 8% Buy | 88% Buy | ||
| Last Month's Opinion | 32% Buy | 56% Sell | 72% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +6.00% since 07/23/26 | +0.34% since 07/23/26 | +1.43% since 07/23/26 | ||
| Low | 61.60 on 07/24/26 | 128.28 on 07/30/26 | 470.67 on 07/30/26 | ||
| High | 65.56 on 07/30/26 | 136.26 on 07/28/26 | 493.61 on 07/28/26 | ||
| 1-Month | |||||
| %Chg | +13.16% since 06/30/26 | +3.93% since 06/30/26 | -3.40% since 06/30/26 | ||
| Low | 56.30 on 07/01/26 | 125.13 on 07/01/26 | 465.00 on 07/23/26 | ||
| High | 65.56 on 07/30/26 | 140.61 on 07/17/26 | 533.67 on 07/07/26 | ||
| 3-Month | |||||
| %Chg | +7.61% since 04/30/26 | +0.36% since 04/30/26 | +12.28% since 04/30/26 | ||
| Low | 53.44 on 06/18/26 | 121.39 on 06/10/26 | 412.27 on 05/05/26 | ||
| High | 65.56 on 07/30/26 | 140.61 on 07/17/26 | 533.67 on 07/07/26 | ||
| 6-Month | |||||
| %Chg | +18.44% since 01/30/26 | -7.50% since 01/30/26 | +2.12% since 01/30/26 | ||
| Low | 53.44 on 06/18/26 | 121.39 on 06/10/26 | 412.27 on 05/05/26 | ||
| High | 65.56 on 07/30/26 | 157.29 on 02/11/26 | 533.67 on 07/07/26 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 128,854,680 | 164,793,568 | 122,671,560 | ||
| Shares Outstanding, K | 2,042,071 | 1,241,570 | 253,805 | ||
| Annual Sales, $M | 48,194,000,000 | 29,443,000,000 | 12,001,300,000 | ||
| Annual Net Income, $M | 7,054,000,000 | 8,510,000,000 | 3,953,200,000 | ||
| Last Qtr Sales, $M | 11,489,000,000 | 6,960,000,000 | 2,986,900,000 | ||
| Last Qtr Income, $M | 2,677,000,000 | 2,021,000,000 | 1,031,400,000 | ||
| 60-Month Beta | 0.23 | 0.32 | 0.29 | ||
| Per-Share Information | |||||
| Most Recent Earnings | 1.58 on 04/30/26 | 2.03 on 05/07/26 | 4.47 on 05/04/26 | ||
| Latest Earnings Date | 07/30/26 | 08/04/26 | 08/03/26 | ||
| Most Recent Dividend | 0.630 on 07/02/26 | 0.820 on 06/15/26 | N/A | ||
| Next Ex-Dividend Date | 07/02/26 | 06/15/26 | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 10.73 | 16.05 | 29.16 | ||